Provision of cancer care during the COVID-19 pandemic

被引：77

作者：

Spicer, James ^{[1
,2
]}

Chamberlain, Charlotte ^{[3
]}

Papa, Sophie ^{[1
,2
]}

机构：

[1] Kings Coll London, Sch Canc & Pharmaceut Sci, London, England

[2] Guys & St Thomas NHS Fdn Trust, London, England

[3] Univ Bristol Sch Med, Populat Hlth Sci, Bristol, Avon, England

来源：

NATURE REVIEWS CLINICAL ONCOLOGY | 2020年 / 17卷 / 06期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1038/s41571-020-0370-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Health-care services are rapidly transforming their organization and workforce in response to the coronavirus disease 2019 (COVID-19) pandemic. These changes, and a desire to mitigate infection risk, are having profound effects on other vital aspects of care, including the care of patients with cancer. Difficult decisions are being made regarding the prioritization of both active treatments and palliative care, despite limited evidence that cancer is an independent risk factor for infection and mortality.

引用

页码：329 / 331

页数：3

共 10 条

[1]

England NHS, 2020, New Technology For Patients Being Tested For Bowel Cancer

[2] Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy [J].

Grasselli, Giacomo ;

Zangrillo, Alberto ;

Zanella, Alberto ;

Antonelli, Massimo ;

Cabrini, Luca ;

Castelli, Antonio ;

Cereda, Danilo ;

Coluccello, Antonio ;

Foti, Giuseppe ;

Fumagalli, Roberto ;

Iotti, Giorgio ;

Latronico, Nicola ;

Lorini, Luca ;

Merler, Stefano ;

Natalini, Giuseppe ;

Piatti, Alessandra ;

Ranieri, Marco Vito ;

Scandroglio, Anna Mara ;

Storti, Enrico ;

Cecconi, Maurizio ;

Pesenti, Antonio .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (16) :1574-1581

[3] Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic [J].

Hanna, Timothy P. ;

Evans, Gerald A. ;

Booth, Christopher M. .

NATURE REVIEWS CLINICAL ONCOLOGY, 2020, 17 (05) :268-270

[4] Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China [J].

Liang, Wenhua ;

Guan, Weijie ;

Chen, Ruchong ;

Wang, Wei ;

Li, Jianfu ;

Xu, Ke ;

Li, Caichen ;

Ai, Qing ;

Lu, Weixiang ;

Liang, Hengrui ;

Li, Shiyue ;

He, Jianxing .

LANCET ONCOLOGY, 2020, 21 (03) :335-337

[5]

Palmieri, 2020, CHARACTERISTICS COVI

[6] Associations between immune-suppressive and stimulating drugs and novel COVID-19-a systematic review of current evidence [J].

Russell, Beth ;

Moss, Charlotte ;

George, Gincy ;

Santaolalla, Aida ;

Cope, Andrew ;

Papa, Sophie ;

Van Hemelrijck, Mieke .

ECANCERMEDICALSCIENCE, 2020, 14 :1-43

[7]

The UK National Institute of Health and Care Excellence, 2020, COVID 19 RAP GUID DE

[8] Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention [J].

Wu, Zunyou ;

McGoogan, Jennifer M. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (13) :1239-1242

[9] Risk of COVID-19 for patients with cancer [J].

Xia, Yang ;

Jin, Rui ;

Zhao, Jing ;

Li, Wen ;

Shen, Huahao .

LANCET ONCOLOGY, 2020, 21 (04) :E180-E180

[10] Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [J].

Zhou, Fei ;

Yu, Ting ;

Du, Ronghui ;

Fan, Guohui ;

Liu, Ying ;

Liu, Zhibo ;

Xiang, Jie ;

Wang, Yeming ;

Song, Bin ;

Gu, Xiaoying ;

Guan, Lulu ;

Wei, Yuan ;

Li, Hui ;

Wu, Xudong ;

Xu, Jiuyang ;

Tu, Shengjin ;

Zhang, Yi ;

Chen, Hua ;

Cao, Bin .

LANCET, 2020, 395 (10229) :1054-1062

← 1 →